Company Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally.
The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer.
It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services.
The company’s pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests.
It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University.
Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
| Country | United States |
| Founded | 1995 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 6,600 |
| CEO | Kevin Conroy |
Contact Details
Address: 5505 Endeavor Lane Madison, Wisconsin 53719 United States | |
| Phone | 608 284 5700 |
| Website | exactsciences.com |
Stock Details
| Ticker Symbol | EXAS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001124140 |
| CUSIP Number | 30063P105 |
| ISIN Number | US30063P1057 |
| Employer ID | 20-4782291 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Kevin T. Conroy J.D. | Chairman of the Board and Chief Executive Officer |
| Jake Orville MBA | Executive Vice President and GM of Screening |
| Brian Baranick | Executive Vice President and General Manager of Precision Oncology |
| Aaron Bloomer | Executive Vice President of Finance |
| Dr. Jorge A. Garces Ph.D. | Chief Science Officer |
| Nassar Nizami | Chief Information Officer |
| Megan Jones | Associate Manager of Investor Relations |
| Tim Caprez | Chief Compliance Counsel and Vice President |
| James Herriott | Senior Vice President, General Counsel and Secretary |
| Sarah Condella | Executive Vice President of Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 13, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 5, 2024 | 10-Q | Quarterly Report |
| Nov 5, 2024 | 8-K | Current Report |
| Oct 8, 2024 | 144 | Filing |
| Oct 7, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Sep 18, 2024 | 144 | Filing |
| Jul 31, 2024 | 10-Q | Quarterly Report |
| Jul 31, 2024 | 8-K | Current Report |
| Jun 25, 2024 | 11-K | Annual report of employee stock purchase, savings and similar plans |